In 1997 was created BioFund Management, which is appeared as VC. The venture was found in Europe in Finland. The leading representative office of defined VC is situated in the Helsinki.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the BioFund Management, startups are often financed by HBM Healthcare Investments AG, MVI Finance, Biotech Turnaround Fund (BTF). The meaningful sponsors for the fund in investment in the same round are HBM Healthcare Investments AG, Sitra, MVI Finance. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Index Ventures, Biofund.
The fund was created by Kalevi Kurkiju00e4rvi. The overall number of key employees were 2.
The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2014. Opposing the other organizations, this BioFund Management works on 13 percentage points more the average amount of lead investments. The high activity for fund was in 2005. The fund is generally included in less than 2 deals every year.
The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FibroGen, Genizon BioSciences, FIT Biotech.
Related Funds
Funds with similar focus
Fund Name | Location |
Arthur Rock & Co | - |
China Super Media Holdings | - |
Flow Traders | Amsterdam, Noord-Holland, The Netherlands |
HG Initiative | - |
Japan startup support Association | Ikeda, Japan, Osaka Prefecture |
Jiuli Jijin | China, Minhang, Shanghai |
K Street Capital | District of Columbia, United States, Washington |
Lu An Industrial | China, Guangdong, Shenzhen |
NetWorth Partners | California, San Diego, United States |
NFP Ventures | New York, New York, United States |
Point King Capital | Australia, New South Wales, Sydney |
ProVen Private Equity | England, London, United Kingdom |
Sanko Holding | Istanbul, Istanbul, Turkey |
Talis Capital | England, London, United Kingdom |
The Shatter Fund | California, San Francisco, United States |
Tom Farms | - |
Xin Ding Capital | Beijing, Beijing, China |
Yaohong Chuangtou | China, Shanghai |
Zhongyi Ningbo Ecological Park | China, Hebei, Zhongyi |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
SpinX | $10M | 06 Sep 2005 | Geneva, Geneva, Switzerland | ||
Hyglos | $9M | 23 Aug 2005 | Bernried, Baden-Wurttemberg, Germany | ||
Ipsat Therapies | $9M | 03 Apr 2005 | Uusimaa | ||
Genizon BioSciences | $8M | 13 Dec 2004 | Montreal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
SpinX | $10M | 06 Sep 2005 | Geneva, Geneva, Switzerland | ||
Hyglos | $9M | 23 Aug 2005 | Bernried, Baden-Wurttemberg, Germany | ||
Ipsat Therapies | $9M | 03 Apr 2005 | Uusimaa | ||
Genizon BioSciences | $8M | 13 Dec 2004 | Montreal, Quebec, Canada |